Connection

Toru Hifumi to Neuroleptic Malignant Syndrome

This is a "connection" page, showing publications Toru Hifumi has written about Neuroleptic Malignant Syndrome.
Connection Strength

0.606
  1. The authors' response: Propofol in COVID 19: From basic science to clinical impact. Am J Emerg Med. 2021 07; 45:528.
    View in: PubMed
    Score: 0.203
  2. The authors' response: A diagnostic confusion between serotonin syndrome and neuroleptic malignant syndrome. Am J Emerg Med. 2021 05; 43:274.
    View in: PubMed
    Score: 0.202
  3. Neuroleptic malignant syndrome in patients with COVID-19. Am J Emerg Med. 2020 10; 38(10):2243.e1-2243.e3.
    View in: PubMed
    Score: 0.201
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.